Ankylosing spondylitis is a dubious disease in the field of autoimmune and rheumatic immunity, clinical manifestations are complex and often involve multiple systemic burdens. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory examinations and pathological activation.
The platform can help to match a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment programs for and management of ankylosing spondylitis require individual development, usually including pharmacotherapy, rehabilitation interventions, regular follow-up, and other multidimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune disorders that were previously difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely scheduling according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of herpes with synthetase syndrome. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.